A key part of our work until 2023 will be improving the management of cholesterol. Good management of cholesterol is important in preventing heart attacks and strokes, but patients with high cholesterol are likely to be asymptomatic.
A number of organisations are also working to support CVD ambitions across the country, such as the British Heart Foundation, Heart UK, NICE, Right Care and Public Health England. We are linking with these organisations.
NHS health checks play a large role in identifying patients who will benefit from preventative interventions.
We will also be looking at improving the management of familial hypercholesterolaemia (FH), a hereditary condition of high cholesterol that is evident from birth but is rarely picked up before the individual has a CVD event. Currently, identification of people with this condition is very low.
Supporting our national ambitions to improve cholesterol management and the identification and management of familial hypercholesterolemia
System levers to achieve CVD ambitions
Public Health England has identified lipids management as a key area of improvement. Over the next three years, the AHSN programme will focus on:
detection of people with FH
improvement in the management of people with resistant high cholesterol
Key national support initiatives
CVDPrevent audit find out more
A national audit that will identify key areas of improvement for primary care, to report in April 2021
Directed Enhanced Service (DES) scheme find out more
A national programme to support primary care in achieving improvements 2021/2022
Accelerated Access Collaborative find out more
A number of products have been funded through this approach, including PCSK9i
Outcomes will be measured in accordance with national metrics:
We currently have several improvement projects with primary and secondary care:
- Liverpool lipids improvement project
- Halton primary care lipids improvement project (Control Cholesterol)
- Knowsley community pharmacy lipids improvement project (Control Cholesterol)